Stephen W. Mason

4.7k total citations
31 papers, 1.7k citations indexed

About

Stephen W. Mason is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Stephen W. Mason has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 13 papers in Molecular Biology and 12 papers in Infectious Diseases. Recurrent topics in Stephen W. Mason's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and RNA and protein synthesis mechanisms (6 papers). Stephen W. Mason is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and RNA and protein synthesis mechanisms (6 papers). Stephen W. Mason collaborates with scholars based in Canada, United States and Germany. Stephen W. Mason's co-authors include Jack Greenblatt, Justin R. Nodwell, Steve Titolo, Nathalie Goudreau, Christopher T. Lemke, Anne‐Marie Faucher, Joyce Li, Brenda Andrews, Yuen Ho and Merl F. Hoekstra and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Stephen W. Mason

31 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen W. Mason Canada	21	921	494	470	392	309	31	1.7k
Gilles Mirambeau France	18	1.1k 1.2×	268 0.5×	421 0.9×	188 0.5×	124 0.4×	29	1.4k
Nicolas Tarbouriech France	25	613 0.7×	319 0.6×	304 0.6×	185 0.5×	671 2.2×	43	1.7k
Michael Sakalian United States	19	441 0.5×	606 1.2×	754 1.6×	178 0.5×	327 1.1×	32	1.4k
Matteo Negroni France	24	637 0.7×	529 1.1×	707 1.5×	166 0.4×	232 0.8×	37	1.2k
P L Callahan United States	9	662 0.7×	496 1.0×	437 0.9×	129 0.3×	332 1.1×	9	1.3k
Zuzana Hostomska United States	14	1.0k 1.1×	694 1.4×	490 1.0×	143 0.4×	378 1.2×	16	1.8k
Wade Blair United States	26	664 0.7×	1.1k 2.1×	1.1k 2.3×	189 0.5×	458 1.5×	45	2.1k
Martin Bisaillon Canada	24	943 1.0×	436 0.9×	136 0.3×	167 0.4×	228 0.7×	73	1.7k
Christoph Grundner United States	21	1.0k 1.1×	668 1.4×	676 1.4×	144 0.4×	354 1.1×	39	1.8k
Jason W. Rausch United States	28	1.0k 1.1×	848 1.7×	940 2.0×	132 0.3×	302 1.0×	55	1.8k

Countries citing papers authored by Stephen W. Mason

Since Specialization

Citations

This map shows the geographic impact of Stephen W. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen W. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen W. Mason more than expected).

Fields of papers citing papers by Stephen W. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen W. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen W. Mason. The network helps show where Stephen W. Mason may publish in the future.

Co-authorship network of co-authors of Stephen W. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen W. Mason. A scholar is included among the top collaborators of Stephen W. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen W. Mason. Stephen W. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bui, John, et al.. (2019). Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART. PLoS ONE. 14(1). e0211112–e0211112. 20 indexed citations

Yarovinsky, Timur O., Stephen W. Mason, Maria Haslip, et al.. (2019). Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B. iScience. 21. 391–402. 11 indexed citations

Mason, Stephen W., John P. DeVincenzo, Stephen Toovey, Jim Zhen Wu, & Richard J. Whitley. (2018). Comparison of antiviral resistance across acute and chronic viral infections. Antiviral Research. 158. 103–112. 54 indexed citations

Balsitis, Scott, Susan Chaniewski, Steven M. LeVine, et al.. (2018). Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection. PLoS ONE. 13(2). e0190058–e0190058. 37 indexed citations

Gay, Cynthia L., Ronald J. Bosch, Justin Ritz, et al.. (2017). Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy. The Journal of Infectious Diseases. 215(11). 1725–1733. 180 indexed citations

Sheaffer, Amy K., Min S. Lee, Huilin Qi, et al.. (2016). A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses. PLoS ONE. 11(6). e0155909–e0155909. 3 indexed citations

Fader, Lee D., Rebekah Carson, Sébastien Morin, et al.. (2014). Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV. ACS Medicinal Chemistry Letters. 5(6). 711–716. 14 indexed citations

Goudreau, Nathalie, René Coulombe, Anne‐Marie Faucher, et al.. (2013). Monitoring Binding of HIV‐1 Capsid Assembly Inhibitors Using ¹⁹F Ligand‐and ¹⁵N Protein‐Based NMR and X‐ray Crystallography: Early Hit Validation of a Benzodiazepine Series. ChemMedChem. 8(3). 405–414. 14 indexed citations

Fader, Lee D., Serge Landry, Sébastien Morin, et al.. (2013). Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification. Bioorganic & Medicinal Chemistry Letters. 23(11). 3396–3400. 15 indexed citations

10.

Goudreau, Nathalie, Oliver Hucke, Anne‐Marie Faucher, et al.. (2013). Discovery and Structural Characterization of a New Inhibitor Series of HIV-1 Nucleocapsid Function: NMR Solution Structure Determination of a Ternary Complex Involving a 2:1 Inhibitor/NC Stoichiometry. Journal of Molecular Biology. 425(11). 1982–1998. 39 indexed citations

11.

Lemke, Christopher T., Steve Titolo, Nathalie Goudreau, et al.. (2013). A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallizationviacompound-mediated dimerization. Acta Crystallographica Section D Biological Crystallography. 69(6). 1115–1123. 27 indexed citations

12.

Tremblay, Martin, Pierre Bonneau, Yves Bousquet, et al.. (2012). Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold. Bioorganic & Medicinal Chemistry Letters. 22(24). 7512–7517. 28 indexed citations

13.

Homon, Carol, Mohammed A. Kashem, Stephen W. Mason, et al.. (2007). Assay Optimization: A Statistical Design of Experiments Approach. Clinics in Laboratory Medicine. 27(1). 139–154. 37 indexed citations

14.

Homon, Carol, Mohammed A. Kashem, Stephen W. Mason, et al.. (2006). Assay Optimization: A Statistical Design of Experiments Approach. JALA Journal of the Association for Laboratory Automation. 11(1). 33–41. 14 indexed citations

15.

Mason, Stephen W.. (2004). Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor. Nucleic Acids Research. 32(16). 4758–4767. 37 indexed citations

16.

Mason, Stephen W., Michael Wallisch, & Ingrid Grummt. (1997). RNA polymerase I transcription termination: similar mechanisms are employed by yeast and mammals 1 1Edited by M. Yaniv. Journal of Molecular Biology. 268(2). 229–234. 26 indexed citations

17.

Mason, Stephen W.. (1997). Identification of a transcript release activity acting on ternary transcription complexes containing murine RNA polymerase I. The EMBO Journal. 16(1). 163–172. 31 indexed citations

18.

Greenblatt, Jack, Justin R. Nodwell, & Stephen W. Mason. (1993). Transcriptional antitermination. Nature. 364(6436). 401–406. 195 indexed citations

19.

Mason, Stephen W., Joyce Li, & Jack Greenblatt. (1992). Direct interaction between two Escherichia coli transcription antitermination factors, NusB and ribosomal protein S10. Journal of Molecular Biology. 223(1). 55–66. 61 indexed citations

20.

Mason, Stephen W. & Jack Greenblatt. (1991). Assembly of transcription elongation complexes containing the N protein of phage lambda and the Escherichia coli elongation factors NusA, NusB, NusG, and S10.. Genes & Development. 5(8). 1504–1512. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact